Ibrutinib With or Without Bortezomib and Dexamethasone in Treating Patients With Relapsed or Refractory Immunoglobulin Light Chain Amyloidosis
Clinical trial NCT03130348 · WITHDRAWN
Trial details
- NCT number
- NCT03130348
- Sponsor
- Mayo Clinic
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-15
- Primary completion
- 2022-04-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.